Moderna Hopeful of Phase 1 Data for COVID-19 Vaccine by Summer, Analyst Reiterates Buy

The images of eerie empty streets, along with the sight of masked civilians roaming around, all add to the sense that we are currently on the set of a dystopian sci-fi movie. Add into the mix the race among pharmaceutical companies to develop a COVID-19 vaccine or treatment, and the drama is further enhanced. But as we all know, this is no screenplay, but current daily life around the globe. Vying for a starring role in this real-life drama is biotech Moderna (MRNA). The messenger RNA specialist is developing mRNA-1273, a vaccine against COVID-19 currently in Phase 1 testing, and …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.